Corporate Responsibility Report

Overview

The report covers Astria Therapeutics' 2024 ESG disclosures and is aligned with IFRS S1, SASB, and the UN SDGs. It highlights patient-centered clinical-trial design and health-equity work, including broad inclusion actions for ALPHA-ORBIT. The company describes a 20+ member Inclusion & Belonging Committee and employee initiatives. Environmental highlights include moving into a LEED Gold building, recycling, reusable serviceware, and replacing 11,426 plastic bottles.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2024
Period: 1 January 2024 – 31 December 2024
Publication date: 1 May 2025
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services